Quick Links

Novel treatment of acute and chronic pain

News

Published: 26 Mar 2004

Antalium Inc. and Neuroceptor Inc., two spin-off companies of McGill and Queen's Universities respectively, have merged to form a new leading-edge biopharmaceutical company called PainCeptor Pharma Corporation. The new company is focused on the development of novel and effective therapeutic drugs for the treatment of acute and chronic pain.

Antalium Inc. and Neuroceptor Inc., two spin-off companies of McGill and Queen's Universities respectively, have merged to form a new leading-edge biopharmaceutical company called PainCeptor Pharma Corporation. The new company is focused on the development of novel and effective therapeutic drugs for the treatment of acute and chronic pain.
Source Site: /channels
Classified as: